Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease
Clinical trial NCT04145037 · TERMINATED
Trial details
- NCT number
- NCT04145037
- Sponsor
- AVROBIO
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-30
- Primary completion
- 2023-08-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.